In 2019, Liu et al. confirmed for the first time that FTO plays a role in the occurrence and development of ESCC, and they demonstrated through qRT-PCR and Western blotting that MMP13 might act as a downstream effector of FTO in ESCC [32]. This evidence concerns the gene MMP13 and esophageal squamous cell carcinoma.